Edgar, Chris

Machine learning for comprehensive forecasting of Alzheimer’s Disease progression

Fisher, C. K., Smith, A. M., Walsh, J. R., Diseases, C. A. M., Simon, A. J., Edgar, C., Jack, C. R., Holtzman, D., Russell, D., Hill, D., et al. (2019) · Scientific Reports

Dementia and Cognitive Impairment ResearchMachine Learning in Healthcare

Cited by 223

Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence

Pace-Schott, E. F., Morgan, P. T., Malison, R. T., Hart, C. L., Edgar, C., Walker, M., & Stickgold, R. (2008) · The American Journal of Drug and Alcohol Abuse

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 88

Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials

Borland, E., Edgar, C., Stomrud, E., Cullen, N., Hansson, O., & Palmqvist, S. (2022) · Neurology

Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studies

Cited by 83

Building clinically relevant outcomes across the Alzheimer's disease spectrum

Rentz, D. M., Wessels, A. M., Annapragada, A. V., Berger, A., Edgar, C. J., Gold, M., Miller, D. S., Randolph, C., Ryan, J. M., Wunderlich, G., et al. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 38

Effects of nicotine withdrawal on cognition in a clinical trial setting

Wesnes, K. A., Edgar, C. J., Kezic, I., Salih, H. M., & de Boer, P. (2013) · Psychopharmacology

Smoking Behavior and CessationNicotinic Acetylcholine Receptors Study

Cited by 31

The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial

Reddy, S., Fayyad, R., Edgar, C. J., Guico-Pabia, C. J., & Wesnes, K. (2016) · Journal of Psychopharmacology

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 17

Cognitive go/No-go decision-making criteria in Alzheimer’s disease drug development

Wessels, A. M., Edgar, C. J., Nathan, P. J., Siemers, E. R., Maruff, P., & Harrison, J. (2021) · Drug Discovery Today

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 7